India Today on MSN
India's next leap: Homegrown biotech push spurs hope for affordable next-gen drugs for cancers, other serious conditions
As Bharat Biotech, Syngene, and others enter next-gen medicine manufacturing, experts see a future where advanced cancer and ...
Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors and market participants. The company develops therapies for conditions ...
Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...
During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America During the first six months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback